Last update:
Oncology news
Urine test outperforms MRI for monitoring low-risk prostate cancer in new study
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use of the test to determine the need for repeat "monitoring" biopsies would have avoided up ...
23 hours ago
0
9
IL-10 gene therapy boosts immune attack against liver cancer in mice
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting immune cells and suppresses liver tumors in mice. The treatment also generated long-lasting immune ...
May 8, 2026
0
3
Technology receives FDA approval for breast cancer treatment
More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering research into PROTACs (or PROteolysis TArgeting Chimera), a technology that treats certain types of cancer ...
May 8, 2026
0
8
Immunologist's lab demonstrates the power of B cells to gather and defend organs against cancer
Creativity and curiosity have always been central to the work of Joshua Moreau, Ph.D., an immunologist whose work at Oregon Health & Science University sits at the intersection of harnessing the immune system; delving into ...
May 8, 2026
0
1
Solving a 15-year mystery: Scientists discover how gut bacteria toxin invades colon cells to trigger cancer
Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of ...
May 7, 2026
0
24
Leukemia stem cells cause treatments to fail, but findings open new avenues to overcome resistance
Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML). They show that there are ...
May 7, 2026
0
8
Despite breakthroughs, many go without treatment for metastatic lung cancer
About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in options over recent decades that have created meaningful improvements in lifespan and quality of life ...
May 7, 2026
0
19
Study identifies new strategy to overcome immunotherapy resistance in colorectal cancer
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a promising new strategy to overcome resistance to immunotherapy in colorectal cancer, one of the leading ...
May 7, 2026
0
6
Cancer cells are better able to resist treatments when they have an abnormal number of chromosomes
A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they have an abnormal number of chromosomes, the DNA strands wound up in bundles that control which genetic ...
May 7, 2026
0
3
Why unusually long telomeres could raise lymphoma risk and reshape cancer monitoring
Researchers at the Johns Hopkins Kimmel Cancer Center and the Telomere Clinic at Johns Hopkins have identified a genetic syndrome in which unusually long telomeres—the protective caps at the ends of chromosomes—allow immune ...
May 7, 2026
0
7
RAS(ON) inhibitor daraxonrasib shows promising results in advanced pancreatic cancer
The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II first-in-human trial led by ...
May 7, 2026
0
3
National study examines genetic testing to inform follow-up care for cancer survivors
Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients ...
May 7, 2026
0
3
Combination therapy with stem cell-derived immune cells boosts anti-cancer response
Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak or too slow to be effective. ...
May 7, 2026
0
3
Lung cancer screening rates up, yet remain low
A new University of Kentucky Markey Cancer Center study published in JAMA Internal Medicine found that lung cancer screening rates among eligible U.S. adults have improved in recent years, but fewer than one in four are getting ...
May 7, 2026
0
2
New ultrasonic needle yields samples 2–3 times larger, potentially reshaping cancer diagnostics
Developed at Aalto University over several years, a new ultrasonic needle for tumor diagnostics has been trialed in collaboration with Helsinki University Hospital (HUS). According to the resulting peer-reviewed study, salivary ...
May 7, 2026
0
1
New MRI technology maps 20-plus brain biomarkers in a single 14-minute scan
New multiplexed imaging technology using standard clinical MRI systems can simultaneously map more than 20 biomarkers in high resolution, providing a comprehensive view of the brain with a single scan.
May 6, 2026
0
17
Testosterone suppresses brain tumor growth in males, study suggests
In a new study, scientists at Cleveland Clinic discovered that hormones associated with male development may play a key role in limiting the growth of brain tumors in men. The research team found that the loss of androgen ...
May 6, 2026
0
24
Direct-to-proteasome strategy degrades two cancer proteins and may curb drug resistance
A preclinical study has developed a strategy that enables the forced elimination of proteins that help tumors survive chemotherapy. This finding opens a new avenue to tackle resistance to cancer treatments, one of the major ...
May 6, 2026
0
8
Blood test reveals nine tumor cell 'neighborhoods' tied to immunotherapy outcomes
A simple blood test can reveal the geographic relationships among healthy cells surrounding a cancerous tumor, researchers at Stanford Medicine and the Mayo Clinic have found. The test is the first noninvasive way to study ...
May 6, 2026
0
10
AI screening tool gives pathologists 'spatial super vision' to detect hidden cancer
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology analysis to give pathologists "super vision" to detect hidden genetic markers of cancer in standard patient ...
May 6, 2026
0
7
One overlooked detail in cancer genomes is rewriting which mutations really matter
It's a fundamental principle of science: Correlation does not equal causation. Every cancer cell has genetic mutations, but not all of those mutations necessarily drive the cancer.
May 6, 2026
0
6
Hidden reservoir may drive brain cancer relapse in 65% of patients
All types of brain cancers collectively have a five-year survival rate of just 33%, according to the National Cancer Institute's Surveillance, Epidemiology, and End Results Program. For a type of brain cancer called glioblastoma, ...
May 6, 2026
0
5
Can AI forecast immune responses? New benchmark shows where predictions hold up and fail
Artificial intelligence is increasingly being used to help scientists accelerate drug discovery and search for new treatments. But for AI tools to work effectively, researchers need to know whether they can be validated and ...
May 6, 2026
0
4
How changes to proteins can alter drug interactions for new precision therapies
Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translational modifications, or PTMs, these can change how a protein folds, where it travels ...
May 6, 2026
0
4
To combat the youth vaping epidemic, AI can help determine which cessation strategies work best
Nationwide, young people ages 18–24 are the heaviest users of e-cigarettes, with 38.4% of youth reporting habitual use. E-cigarettes are also very popular in Western New York, with significantly higher use than in New York ...
May 6, 2026
0
4
